Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery

This study has been completed.
Information provided by (Responsible Party):
Daniel Carradice, University of Hull Identifier:
First received: October 29, 2009
Last updated: May 30, 2014
Last verified: May 2014
Dialysis patients have their blood filtered by a machine as their kidneys no longer work. To get blood in and out of these patients it is possible to perform a surgical procedure to increase to size and durability of a vein in the arm to allow repeated needle insertion. This enlarged vein is called a fistula. There is some evidence that ultrasound scanning the blood vessels in the arm before surgery can improve the chances of a successful procedure. The investigators aim to test whether scanning all patients is better than scanning only those who are difficult to assess by physical examination alone.

Condition Intervention Phase
End Stage Renal Failure
Procedure: Arterial and venous duplex ultrasound examination
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Prospective Randomized Controlled Trial of the Clinical Effectiveness of Obligatory Versus Elective Duplex Ultrasound Scanning Prior to Arteriovenous Fistula Formation for Haemodialysis Vascular Access in a University Teaching Hospital.

Resource links provided by NLM:

Further study details as provided by Daniel Carradice, University of Hull:

Primary Outcome Measures:
  • Primary failure of access (immediate/early thrombosis or failure to mature). [ Time Frame: 30 days ]

Secondary Outcome Measures:
  • Assisted primary patency - being the interval from placement until the time of measurement of patency, including intervening manipulations [ Time Frame: open ended ]
  • Secondary patency - The interval from placement until time of patency measurement including intervening manipulations [ Time Frame: open ended ]
  • Site of fistula created [ Time Frame: within 1 month of recruitment ]
  • Functional primary patency - being the interval from the time of access placement until any intervention designed to maintain or re-establish patency or the time of measurement of patency during which the AVF provides dialysis access. [ Time Frame: open ended ]
  • Surgeon grade [ Time Frame: open ended ]

Other Outcome Measures:
  • Microparticle concentration [ Time Frame: open ]
    Blood tests will be taken at baseline, 1, 3 and 6 months to investigate the impact of concentrations on patency

  • Circulating tissue factor concentration [ Time Frame: open ]
    Blood test to be taken at baseline, 1, 3 and 6 months and examined using ELISA to establish the impact of tissue factor concentrations on patency

Enrollment: 98
Study Start Date: March 2010
Study Completion Date: January 2012
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control group - selective duplex
Patients will receive a duplex ultrasound only if specifically requested following physical examination.
Experimental: Obligatory Duplex scan
Patients will receive a duplex ultrasound regardless of clinical findings. Arterial and venous duplex ultrasound examination
Procedure: Arterial and venous duplex ultrasound examination
Ultrasound mapping of all blood vessels in the upper limb of interest

Detailed Description:
We will recruit all patients undergoing primary vascular access procedures in our unit who meet inclusion criteria. They will be randomised to either surgery based on clinical findings with duplex ultrasound only if requested by surgeon, or routine duplex ultrasound prior to surgery.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Specific inclusion criteria necessary for invitation to study participation; Patients referred to vascular consultants for primary AV fistula formation (or primary fistula in that limb) for haemodialysis access.

General inclusion criteria;

  • Ability to give informed written consent

Exclusion Criteria:

  • Specific exclusion criteria;

    • Previous arterial or venous surgery/intervention performed on target limb.
    • Known thrombophilic or thrombotic pathology.
    • Aged under 18 at time of referral

General exclusion criteria;

  • Inability to give informed written consent
  • Inability to attend follow up appointments
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01004627

United Kingdom
Hull Royal Infirmary
Hull, United Kingdom, HU3 2JZ
Sponsors and Collaborators
University of Hull
Principal Investigator: Ian C Chetter, MBChB FRCS MD Hull University
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Daniel Carradice, DCarradice, University of Hull Identifier: NCT01004627     History of Changes
Other Study ID Numbers: Access 1
Study First Received: October 29, 2009
Last Updated: May 30, 2014

Keywords provided by Daniel Carradice, University of Hull:
preoperative vein mapping
Angioaccess surgery

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Kidney Diseases
Urologic Diseases
Pathological Conditions, Anatomical processed this record on May 25, 2017